Does ELRANATAMAB-BCMM Cause Condition aggravated? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Condition aggravated have been filed in association with ELRANATAMAB-BCMM. This represents 1.4% of all adverse event reports for ELRANATAMAB-BCMM.
8
Reports of Condition aggravated with ELRANATAMAB-BCMM
1.4%
of all ELRANATAMAB-BCMM reports
0
Deaths
3
Hospitalizations
How Dangerous Is Condition aggravated From ELRANATAMAB-BCMM?
Of the 8 reports, 3 (37.5%) required hospitalization.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELRANATAMAB-BCMM. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does ELRANATAMAB-BCMM Cause?
Cytokine release syndrome (115)
Death (51)
Pyrexia (46)
Fatigue (31)
Neoplasm progression (31)
Cytomegalovirus infection reactivation (29)
Malignant neoplasm progression (27)
Off label use (27)
Immune effector cell-associated neurotoxicity syndrome (26)
Infection (25)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which ELRANATAMAB-BCMM Alternatives Have Lower Condition aggravated Risk?
ELRANATAMAB-BCMM vs ELTROMBOPAG
ELRANATAMAB-BCMM vs ELTROMBOPAG OLAMINE
ELRANATAMAB-BCMM vs ELUXADOLINE
ELRANATAMAB-BCMM vs ELVITEGRAVIR
ELRANATAMAB-BCMM vs EMAPALUMAB